Study Confirms Breast Cancer Risk in Continuous Combined Hormone Therapy Risk Begins to Return to Normal After Women Stop Taking Hormones
Researchers confirmed that a daily, combined dose of estrogen and progestin increases breast cancer risk in post menopausal women, but added that this risk begins to return to normal about six months after women stop taking the hormones.